Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8452 |
Intermediate Similarity |
NPD37 |
Approved |
0.8408 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8408 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8408 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8302 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8129 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.8086 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.8085 |
Intermediate Similarity |
NPD3705 |
Approved |
0.8061 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7988 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.787 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7736 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7633 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7595 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.759 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7588 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7586 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7574 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7548 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7533 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7515 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7455 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7452 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7442 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.74 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7394 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7391 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7384 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7356 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7341 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7337 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.733 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7324 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7321 |
Intermediate Similarity |
NPD919 |
Approved |
0.7314 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7308 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7297 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7263 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7262 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7261 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.726 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7257 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7255 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7251 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7248 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7248 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7246 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7241 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7229 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7228 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7216 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7207 |
Intermediate Similarity |
NPD6842 |
Approved |
0.7207 |
Intermediate Similarity |
NPD6843 |
Phase 3 |
0.7207 |
Intermediate Similarity |
NPD6841 |
Approved |
0.7202 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7193 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7186 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7171 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.717 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7166 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7161 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.716 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7159 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7151 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7124 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7117 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7117 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7117 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7115 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7115 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7112 |
Intermediate Similarity |
NPD5005 |
Approved |
0.7112 |
Intermediate Similarity |
NPD5006 |
Approved |
0.7107 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7107 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7102 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7102 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7083 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7081 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7055 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7051 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7044 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7037 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7035 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7022 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7013 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7011 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7011 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7011 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.6995 |
Remote Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.6989 |
Remote Similarity |
NPD4420 |
Approved |
0.6989 |
Remote Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.6983 |
Remote Similarity |
NPD8312 |
Approved |
0.6983 |
Remote Similarity |
NPD8313 |
Approved |
0.6982 |
Remote Similarity |
NPD2801 |
Approved |
0.698 |
Remote Similarity |
NPD4626 |
Approved |
0.6975 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6975 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6964 |
Remote Similarity |
NPD6386 |
Approved |
0.6964 |
Remote Similarity |
NPD5089 |
Approved |
0.6964 |
Remote Similarity |
NPD5090 |
Approved |
0.6964 |
Remote Similarity |
NPD6385 |
Approved |
0.6951 |
Remote Similarity |
NPD4357 |
Discontinued |
0.6941 |
Remote Similarity |
NPD5402 |
Approved |
0.6941 |
Remote Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.6937 |
Remote Similarity |
NPD3539 |
Phase 1 |
0.6933 |
Remote Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.6932 |
Remote Similarity |
NPD3751 |
Discontinued |
0.6928 |
Remote Similarity |
NPD920 |
Approved |
0.6923 |
Remote Similarity |
NPD6801 |
Discontinued |
0.6923 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6918 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6914 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6914 |
Remote Similarity |
NPD1243 |
Approved |
0.6913 |
Remote Similarity |
NPD1357 |
Approved |
0.6908 |
Remote Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.6905 |
Remote Similarity |
NPD4380 |
Phase 2 |
0.6905 |
Remote Similarity |
NPD7028 |
Phase 2 |
0.6903 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6901 |
Remote Similarity |
NPD1358 |
Approved |
0.6899 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6899 |
Remote Similarity |
NPD230 |
Phase 1 |
0.6899 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6897 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6894 |
Remote Similarity |
NPD3540 |
Phase 1 |
0.6891 |
Remote Similarity |
NPD8151 |
Discontinued |
0.689 |
Remote Similarity |
NPD7124 |
Phase 2 |
0.6887 |
Remote Similarity |
NPD422 |
Phase 1 |
0.6887 |
Remote Similarity |
NPD1611 |
Approved |
0.6887 |
Remote Similarity |
NPD1281 |
Approved |
0.6887 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6883 |
Remote Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.6882 |
Remote Similarity |
NPD5563 |
Clinical (unspecified phase) |
0.6882 |
Remote Similarity |
NPD4585 |
Approved |
0.6871 |
Remote Similarity |
NPD4628 |
Phase 3 |
0.6868 |
Remote Similarity |
NPD8434 |
Phase 2 |
0.6859 |
Remote Similarity |
NPD4625 |
Phase 3 |
0.6845 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6842 |
Remote Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.6839 |
Remote Similarity |
NPD2861 |
Phase 2 |
0.6839 |
Remote Similarity |
NPD6959 |
Discontinued |
0.6832 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6831 |
Remote Similarity |
NPD3134 |
Approved |
0.6829 |
Remote Similarity |
NPD6190 |
Approved |
0.6826 |
Remote Similarity |
NPD5403 |
Approved |
0.6818 |
Remote Similarity |
NPD4481 |
Phase 3 |
0.6813 |
Remote Similarity |
NPD6111 |
Discontinued |
0.6807 |
Remote Similarity |
NPD5401 |
Approved |
0.6807 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6807 |
Remote Similarity |
NPD642 |
Clinical (unspecified phase) |
0.68 |
Remote Similarity |
NPD5585 |
Approved |
0.6795 |
Remote Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.6793 |
Remote Similarity |
NPD7235 |
Clinical (unspecified phase) |
0.6792 |
Remote Similarity |
NPD3657 |
Discovery |
0.6788 |
Remote Similarity |
NPD643 |
Clinical (unspecified phase) |
0.6776 |
Remote Similarity |
NPD1091 |
Approved |
0.6772 |
Remote Similarity |
NPD8032 |
Phase 2 |
0.677 |
Remote Similarity |
NPD4108 |
Discontinued |
0.6768 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6765 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6765 |
Remote Similarity |
NPD7411 |
Suspended |
0.6763 |
Remote Similarity |
NPD3749 |
Approved |
0.6763 |
Remote Similarity |
NPD4055 |
Discovery |
0.6755 |
Remote Similarity |
NPD17 |
Approved |
0.6753 |
Remote Similarity |
NPD1283 |
Approved |
0.6752 |
Remote Similarity |
NPD7095 |
Approved |
0.6747 |
Remote Similarity |
NPD1511 |
Approved |
0.6747 |
Remote Similarity |
NPD5297 |
Approved |
0.6746 |
Remote Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.6746 |
Remote Similarity |
NPD4005 |
Discontinued |
0.6746 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.673 |
Remote Similarity |
NPD3620 |
Phase 2 |
0.673 |
Remote Similarity |
NPD4140 |
Approved |
0.673 |
Remote Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.6728 |
Remote Similarity |
NPD2531 |
Phase 2 |
0.6728 |
Remote Similarity |
NPD6099 |
Approved |
0.6728 |
Remote Similarity |
NPD6100 |
Approved |
0.6725 |
Remote Similarity |
NPD3384 |
Approved |
0.6725 |
Remote Similarity |
NPD3383 |
Approved |
0.6725 |
Remote Similarity |
NPD3382 |
Approved |
0.6723 |
Remote Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.672 |
Remote Similarity |
NPD7296 |
Approved |
0.6711 |
Remote Similarity |
NPD3496 |
Discontinued |
0.671 |
Remote Similarity |
NPD3267 |
Approved |
0.671 |
Remote Similarity |
NPD3266 |
Approved |
0.671 |
Remote Similarity |
NPD2797 |
Approved |
0.6709 |
Remote Similarity |
NPD5111 |
Phase 2 |
0.6709 |
Remote Similarity |
NPD5109 |
Approved |
0.6709 |
Remote Similarity |
NPD5110 |
Phase 2 |
0.6709
|
Remote Similarity |
NPD6798 |
Discontinued |